Machine learning identifies depression as key barrier to chatbot-delivered insomnia therapy adherence

Consumers could benefit from more personalized digital mental health interventions with improved adherence rates, potentially reducing out-of-pocket costs for therapy and medication. However, those with comorbid depression may require hybrid care models combining chatbots with human support, potentially increasing costs for this vulnerable population.

Regulators may establish guidelines for AI-driven mental health screening and comorbidity detection in digital therapeutics. Insurance coverage policies could shift toward reimbursing chatbot-delivered CBT-I with predictive analytics for patient stratification. Mental health parity laws may require coverage for hybrid digital-human care models for high-risk populations identified by machine learning.